Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00812669
What this trial is testing

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Who this might be right for
Leukemia
Cancer Trials Ireland 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00004112
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)UnknownNCT05200312
What this trial is testing

A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 36
Large-scale testing (Phase 3)UnknownNCT00003725
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals 300
Testing effectiveness (Phase 2)Ended earlyNCT01322815
What this trial is testing

A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

Who this might be right for
Colon Cancer
Georgetown University 11
Very early researchStudy completedNCT01822015
What this trial is testing

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 55
Testing effectiveness (Phase 2)Study completedNCT04801147
What this trial is testing

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 76
Early research (Phase 1)Active Not RecruitingNCT03587038
What this trial is testing

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Oklahoma 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04023526
What this trial is testing

Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
OncoVerity, Inc. 103
Testing effectiveness (Phase 2)Ended earlyNCT00250835
What this trial is testing

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

Who this might be right for
Rectal Cancer
New Mexico Cancer Research Alliance 38
Large-scale testing (Phase 3)UnknownNCT03942094
What this trial is testing

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseNilotinib
Shenzhen Second People's Hospital 100
Testing effectiveness (Phase 2)UnknownNCT01042522
What this trial is testing

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Who this might be right for
Ovarian Granulosa Cell TumorOvarian GynandroblastomaOvarian Sertoli-Leydig Cell Tumor+4 more
GOG Foundation 63
Testing effectiveness (Phase 2)WithdrawnNCT01055301
What this trial is testing

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT02928575
What this trial is testing

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Bassam Abdulkarim 45
Not applicableStudy completedNCT02458651
What this trial is testing

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

Who this might be right for
Non-Small Cell Lung Cancer, Lung Cancer, Cancer
Hoffmann-La Roche 1,378
Large-scale testing (Phase 3)Study completedNCT05197257
What this trial is testing

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Colorado, Denver 39
Testing effectiveness (Phase 2)Study completedNCT01101880
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
University of Washington 50
Testing effectiveness (Phase 2)Study completedNCT02805179
What this trial is testing

High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Who this might be right for
Glioma
University of Michigan Rogel Cancer Center 26
Post-approval studies (Phase 4)Study completedNCT00686725
What this trial is testing

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 99
Next Page